1. Home
  2. CVBF vs TLX Comparison

CVBF vs TLX Comparison

Compare CVBF & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVB Financial Corporation

CVBF

CVB Financial Corporation

HOLD

Current Price

$22.46

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.66

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVBF
TLX
Founded
1974
2015
Country
United States
Australia
Employees
N/A
1184
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.6B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CVBF
TLX
Price
$22.46
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$24.50
$21.13
AVG Volume (30 Days)
1.5M
202.9K
Earning Date
04-22-2026
08-19-2026
Dividend Yield
3.95%
N/A
EPS Growth
5.56
N/A
EPS
0.38
N/A
Revenue
N/A
N/A
Revenue This Year
$21.47
N/A
Revenue Next Year
$15.21
N/A
P/E Ratio
$59.11
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$17.95
$6.28
52 Week High
$22.57
$16.95

Technical Indicators

Market Signals
Indicator
CVBF
TLX
Relative Strength Index (RSI) 67.58 62.06
Support Level $18.20 $9.46
Resistance Level N/A $11.28
Average True Range (ATR) 0.49 0.28
MACD 0.16 0.17
Stochastic Oscillator 88.50 77.15

Price Performance

Historical Comparison
CVBF
TLX

About CVBF CVB Financial Corporation

CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: